*Vibrio fluvialis* is commonly encountered \[[@CIT0001]\], being the fifth commonest species (6%) among 1252 cases of *Vibrio* infection reported to the Centers for Disease Control and Prevention \[[@CIT0002]\]. *V. fluvialis* is increasingly recognized as a foodborne pathogen associated with poor sanitation and increased seafood consumption \[[@CIT0001]\]. Acute gastroenteritis is the most common presentation, although extra-intestinal infections have been reported infrequently \[[@CIT0001]\]. Here, we report a case of *V. fluvialis* liver abscess with concomitant bacteremia and review the literature regarding extra-intestinal, including bacteremic, *V. fluvialis* infections.

CASE PRESENTATION {#s1}
=================

A 65-year-old man with a history of pancreatic head cancer and surgically resected bladder cancer presented to the outpatient clinic following 1 week of lethargy. He denied any abdominal pain, diarrhea, or other gastrointestinal symptoms. He was expected to receive chemotherapy for pancreatic cancer; however, he was admitted to the internal medicine ward because of profound hypotension and tachycardia. Twelve months before, pancreatic duct dilation was incidentally noted on follow-up computed tomography for bladder cancer. He was subsequently diagnosed with pancreatic head cancer following bile duct biopsy via endoscopic retrograde cholangiopancreatography. He underwent 2 biliary stent placements and 2 chemotherapy courses with gemcitabine and nab-paclitaxel 7 months before presentation. He gradually lost appetite and mainly consumed sashimi, a Japanese seafood delicacy, purchased at a nearby fish market on a daily basis.

Upon admission, he was alert and oriented with mild lethargy. Physical examination revealed moderate conjunctival pallor, but no focal findings, including abdominal tenderness or peritoneal signs. Complete blood count results were as follows: white blood cell count, 21.5×10^3^/μL; hemoglobin, 7.7 mg/dL; and platelet count, 34.4×10^4^/μL. Liver enzyme levels were as follows: aspartate transaminase, 34 U/L; alanine transaminase, 20 U/L; gamma-glutamyl transpeptidase, 132 U/L; alkaline phosphatase, 652 U/L; and total bilirubin, 0.5 mg/dL. Urinalysis and chest radiogram were unremarkable. Abdominal ultrasound revealed a low echoic lesion \~20 mm in size in segment 6 of the liver. This finding was confirmed with computed tomography with intravenous contrast, which showed a newly identified space-occupying lesion compatible with liver abscess in the corresponding location ([Figure 1A](#F1){ref-type="fig"}). He subsequently underwent fluid resuscitation and percutaneous transhepatic abscess aspiration with empiric piperacillin-tazobactam. The following day, blood cultures and aspirate from the liver abscess were positive for gram-negative bacilli ([Figures 1B](#F1){ref-type="fig"} and [C](#F1){ref-type="fig"}). Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS; Bruker, Billerica, MA, USA) identified *V. fluvialis* (score of 2.129). Antimicrobial susceptibility testing revealed that the isolate was sensitive to ampicillin, ampicillin/sulbactam, piperacillin/tazobactam (minimal inhibitory concentration of 8 μg/mL), cefmetazole, ceftriaxone, ceftazidime, cefepime, aztreonam, meropenem, amikacin, minocycline, and levofloxacin. Because the abscess failed to decrease in size with the initial antibiotic treatment alone, minocycline and piperacillin/tazobactam were administered, along with additional biliary stent placement and percutaneous transhepatic abscess drainage.

![A) A computed tomography scan depicting a low-density area compatible with liver abscess (white arrow). B) *Vibrio fluvialis* colony growing on thiosulfate-citrate-bile-sucrose agar plate. C) Gram stain of blood culture depicting curved gram-negative bacilli (black arrow).](ofaa212f0001){#F1}

After 3 weeks of parenteral antibiotic treatment, the regimen was switched to enteral clindamycin and minocycline. He was discharged and completed 6 weeks of treatment, achieving radiographic liver abscess resolution. The patient died from progression of pancreatic head cancer 6 months after this episode without any recurrence of *V. fluvialis* infection.

DISCUSSION {#s2}
==========

*V. fluvialis* is prevalent in aquatic environments and seafood, which are the main risk factors for acquiring the disease \[[@CIT0001]\]. Gastroenteritis is the most common clinical manifestation \[[@CIT0001]\], and only few extra-intestinal infections have been reported \[[@CIT0001]\]. Here, we review clinically relevant reports of 7 extra-intestinal infection cases including 7 bacteremia cases ([Table 1](#T1){ref-type="table"}) \[[@CIT0003]\]. Cases were mainly from island and peninsular regions \[[@CIT0003]\]. Patients were typically middle-aged, with a 52-year median age, except for 1 infant \[[@CIT0003]\]. There was no sex difference overall; however, 5 of 6 bacteremia cases occurred in male patients with ≥1 comorbidity, primarily diabetes mellitus \[[@CIT0003]\]. Water or seafood exposure was noted in approximately half of cases \[[@CIT0003]\]. Most bacteremia cases resulted from severe gastroenteritis, and 50% of patients died \[[@CIT0003]\]. Extra-intestinal cases included 2 peritonitis cases, 1 hemorrhagic cellulitis, cerebritis, otitis externa, urinary tract infection, and cholangitis case; however, liver abscess has never been reported. Treatment was variable across cases, although combination therapy involving beta-lactams and agents, including aminoglycosides, quinolones, and tetracyclines, was used \[[@CIT0003]\].

###### 

Literature Review of Extra-intestinal Infection Including Bacteremia by *V. fluvialis*

  Case   Age, y   Sex      Country       Site of Disease                     Bacteremia   Underlying Disease                                                              Route of Acquisition                      Treatment                                                                     Outcome    Reference
  ------ -------- -------- ------------- ----------------------------------- ------------ ------------------------------------------------------------------------------- ----------------------------------------- ----------------------------------------------------------------------------- ---------- -----------
  1      40       Female   Taiwan        Otitis externa                      No           None                                                                            Seawater exposure                         AMPC/CVA                                                                      Survived   3
  2      88       Female   Taiwan        Cholangitis                         No           DM, ESRD, cirrhosis, intrahepatic ductal stones                                 None                                      PIPC/TAZ + trans-hepatic biliary drainage                                     Survived   4
  3      52       Female   South Korea   Peritonitis                         No           None, postabdominal blunt injury from traffic accident                          None                                      Cephamycin + netilmicin, PIPC/TAZ + MNZ, cefoperazone + prepenem + amikacin   Died       5
  4      40       Female   USA           Gastroenteritis catheter            Yes          DM, hypertension, ESRD (on HD)                                                  Seawater exposure                         CTRX + DOXY, gatifloxacin                                                     Survived   6
  5      66       Male     Korea         Unknown                             Yes          Gastric cancer                                                                  NA                                        NA                                                                            Died       7
  6      70       Male     Korea         Gastroenteritis                     Yes          DM, hypertension, gastric cancer                                                NA                                        SBT/CPZ + ISP                                                                 Survived   7
  7      65       Male     Taiwan        Gastroenteritis                     Yes          DM, chronic liver disease                                                       None                                      CXM to ST                                                                     Survived   8
  8      55       Female   New Zealand   Peritonitis                         No           ESRD (on CAPD), DM                                                              Seafood                                   CTRX CPFX AMPC + GM ip                                                        Survived   9
  9      45       Male     Taiwan        Hemorrhagic cellulitis cerebritis   Yes          Alcoholic liver disease                                                         Fire ant bites, brackish water exposure   OXA + GM CAZ + oxytetracycline + fasciotomy + left transfemoral amputation    Died       10
  10     5 mo     Male     Bangladesh    Gastroenteritis                     Yes          Malnutrition                                                                    NA                                        ABPC + GM + amdinocillin pivoxil                                              Died       11
  11     52       Female   Lebanon       Urinary tract infection             No           Fibroid uterus, post--total abdominal hysterectomy and bilateral oophorectomy   Home tap water                            CPFX                                                                          Survived   13
  12     65       Male     Japan         Liver abscess                       Yes          Malnutrition, pancreatic cancer, bladder cancer (surgically resected)           Seafood                                   PIPC/TAZ + MINO, CLDM + MINO, biliary stent placement, PTAD                   Survived   Our case

Abbreviations: ABPC, ampicillin; AMPC, amoxicillin; AMPC/CVA, amoxicillin/clavulanate; CAPD, continuous ambulatory peritoneal dialysis; CAZ, ceftazidime; CLDM, clindamycin; CPFX, ciprofloxacin; CTRX, ceftriaxone; CXM, cefuroxime; DM, diabetes mellitus; ESRD, end-stage renal disease; GM, gentamicin; HD, hemodialysis; ip, intraperitoneal; ISP, isepamicin; MINO, minocycline; NA, not available; OXA, oxacillin; PIPC/TAZ, piperacillin/tazobactam; PTAD, percutaneous transhepatic abscess drainage; SBT/CPZ, sulbactam-cefperazone; ST, trimethoprim-sulfamethoxazole.

The scarcity of extra-intestinal and bacteremia cases may partly be because of difficulty in identifying *V. fluvialis* \[[@CIT0001]\]. Although classical thiosulfate-citrate-bile salts-sucrose agar medium and biochemical assays, including API20E and Vitek GNI+ systems, are often used for identification, different *Vibrio* species may show similar results \[[@CIT0001]\]. *V. fluvialis* is closely related to *V. furnissii*, and differentiation may be difficult \[[@CIT0012], [@CIT0014]\]. Both species were originally classified as *V. fluvialis*; however, *V. furnissii* was later distinguished as separate owing to its gas-producing capability \[[@CIT0014]\]. Besides biochemical identification methods, more reliable identification methods include polymerase chain reaction (PCR) DNA testing or MALDI-TOF MS \[[@CIT0012], [@CIT0014]\]. PCR results, using *rpoB* and the more conventional *toxR* gene segment, and MALDI-TOF MS results completely agreed in 1 study \[[@CIT0014]\].

In line with reported cases, our patient was a middle-aged man with biliary tract disease owing to pancreatic cancer who was receiving chemotherapy. MALDI-TOF MS (Bruker, USA) reliably identified *V. fluvialis*. We presume that he acquired *V. fluvialis* from sashimi. Both the liver abscess and bacteremia were successfully treated with combination therapy and aggressive drainage.

In summary, while gastroenteritis is the most common presentation, extra-intestinal *V. fluvialis* infection is uncommon and exhibits high mortality. Heavy seafood consumption is a major risk factor \[[@CIT0001]\]. As raw seafood consumption is getting more common than before worldwide, physicians should consider *V. fluvialis* infection alongside other *Vibrio* species in patients with heavy exposure to seafood, including sashimi.
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